Publications of Matthias L. Schroeter

Oeckl, P., Anderl-Straub, S., Danek, A., Diehl-Schmid, J., Fassbender, K., Fliessbach, K., … Otto, M. (2022). Relationship of serum beta-synuclein with blood biomarkers and brain atrophy. Alzheimer's and Dementia. doi:10.1002/alz.12790

Katzdobler, S., Nitschmann, A., Barthel, H., Bischof, G., Beyer, L., Marek, K., … Brendel, M. (2022). Additive value of [18 F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-022-05964-w

Aghakhanyan, G., Rullmann, M., Rumpf, J., Schroeter, M. L., Scherlach, C., Patt, M., … Barthel, H. (2022). Interplay of tau and functional network connectivity in progressive supranuclear palsy: A [18F]PI-2620 PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-022-05952-0

Koutsouleris, N., Pantelis, C., Velakoulis, D., McGuire, P., Dwyer, D. B., Urquijo-Castro, M.-F., … PRONIA Consortium. (2022). Exploring links between psychosis and frontotemporal dementia using multimodal machine learning: Dementia praecox revisited. JAMA Psychiatry, 79, 907–919.

Röhr, S., Pabst, A., Baber, R., Engel, C., Glaesmer, H., Hinz, A., … Riedel-Heller, S. G. (2022). Social determinants and lifestyle factors for brain health: Implications for risk reduction of cognitive decline and dementia. Scientific Reports, 12. doi:10.1038/s41598-022-16771-6

Polyakova, M., Mueller, K., Arélin, K., Lampe, L., Rodriguez, F. S., Luck, T., … Schroeter, M. L. (2022). Increased serum NSE and S100B indicate neuronal and glial alterations in subjects under 71 years with mild neurocognitive disorder/mild cognitive impairment. Frontiers in Cellular Neuroscience, 16. doi:10.3389/fncel.2022.788150

Kornej, J., Friedrich, K., Schroeter, M. L., Witte, A. V., Polyakova, M., Villringer, A., … Zeynalova, S. (2022). PR interval duration is associated with the presence of white matter hyperintensities: Insights from the epidemiologic LIFE-Adult Study. PLoS One, 17. doi:10.1371/journal.pone.0269815

Hussenoeder, F. S., Pabst, A., Conrad, I., Löbner, M., Engel, C., Zeynalova, S., … Riedel-Heller, S. G. (2022). Anxiety and food addiction in men and women: Results from the longitudinal LIFE-adult-study. Frontiers in Psychiatry, 13. doi:10.3389/fpsyt.2022.914358

Engel, C., Wirkner, K., Zeynalova, S., Baber, R., Binder, H., Ceglarek, U., … LIFE-Adult-Study working group. (2022). Cohort profile: The LIFE-adult-study. International Journal of Epidemiology. doi:10.1093/ije/dyac114

Taubert, H., Schroeter, M. L., Sander, C., & Kluge, M. (2022). Non-right handedness is associated with more time awake after sleep onset and higher daytime sleepiness than right handedness: Objective (actigraphic) and subjective data from a large community sample. Nature and Science of Sleep, 14, 877–890.

Lampe, L., Niehaus, S., Huppertz, H.-J., Merola, A., Reinelt, J., Mueller, K., … Schroeter, M. L. (2022). Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes. Alzheimer's Research & Therapy, 14. doi:10.1186/s13195-022-00983-z

Rullmann, M., Brendel, M., Schroeter, M. L., Saur, D., Levin, J., Perneczky, R. G., … Barthel, H. (2022). Multicenter 18F-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer’s disease. Biomolecules, 12. doi:10.3390/biom12030458

Schroeter, M. L. (2022). Beyond attention, executive function & memory: Re‐socializing cerebral small vessel disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18, 378–379.

Leonhardi, J., Barthel, H., Speerforck, S., Dietzel, J., Schroeter, M. L., Saur, D., … Sabri, O. (2022). Differential diagnosis between Alzheimer’s disease-related depression and pseudo-dementia in depression: A new indication for amyloid-β imaging? Journal of Alzheimer's Disease, 88, 1029–1035.

Seckin, M., Ricard, I., Raiser, T., Heitkamp, N., Ebert, A., Prix, C., … Danek, A. (2022). Utility of the repeat and point test for subtyping patients with primary progressive aphasia. Alzheimer Disease and Associated Disorders, 36, 44–51.

Torrecuso, R., Mueller, K., Holiga, Š., Sieger, T., Vymazal, J., Růžička, F., … Möller, H. E. Improving fMRI in Parkinson's disease by accounting for brain region-specific activity patterns. NeuroImage: Clinical. Retrieved from http://hdl.handle.net/21.11116/0000-000B-0D91-3

Anderl‐Straub, S., Lausser, L., Lombardi, J., Uttner, I., Fassbender, K., Fliessbach, K., … FTLD Consortium. (2021). Predicting disease progression in behavioral variant frontotemporal dementia. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 13. doi:10.1002/dad2.12262

Girbardt, J., Luck, T., Kynast, J., Rodriguez, F. S., Wicklein, B., Wirkner, K., … Rauscher, F. G. (2021). Reading cognition from the eyes: Association of retinal nerve fiber layer thickness with cognitive performance in a population-based study. Brain Communications, 3. doi:10.1093/braincomms/fcab258

Song, M., Beyer, L., Kaiser, L., Barthel, H., van Eimeren, T., Marek, K., … Brendel, M. (2021). Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Journal of Cerebral Blood Flow and Metabolism, 41, 2957–2972.

Song, M., Scheifele, M., Barthel, H., van Eimeren, T., Beyer, L., Marek, K., … German Imaging Initiative for Tauopathies (GII4T). (2021). Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy. European Journal of Nuclear Medicine and Molecular Imaging, 48, 3872–3885.